Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
Saved in:
| Title: | Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment. |
|---|---|
| Authors: | Shah PV; Department of Hematology Oncology, Zuckerberg Cancer Center, Northwell Health Cancer Institute, New Hyde Park, NY, USA., Gladstone DE; Department of Hematology Oncology, Zuckerberg Cancer Center, Northwell Health Cancer Institute, New Hyde Park, NY, USA. dgladstone@northwell.edu. |
| Source: | Current treatment options in oncology [Curr Treat Options Oncol] 2025 Aug; Vol. 26 (8), pp. 754-763. Date of Electronic Publication: 2025 Jul 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
